Include: 24 videos 2 pdfs, size: 7.47 GB
Directed by David Andrew McLain, MD, FACP, FACR
McLAIN MEDICAL ASSOCIATES, P.C.
The Congress of Clinical Rheumatology is a comprehensive program with an international perspective designed for clinical rheumatologists to emphasize pertinent, emerging issues, and cutting edge advancements in rheumatology that can be directly implemented in practice to improve patient care. Learn from the best in the comfort of your home or office.
Description
This program is intended for Clinical Rheumatologists and other physicians who are directly involved in the care and management of rheumatic disease patients. The emphasis of this course is on cutting edge advancements and pertinent, emerging issues in clinical rheumatology.
Intended Audience
Although intended primarily for clinical rheumatologists, the Congress of Clinical Rheumatology is also of great interest and value to physicians or other health care personnel who are directly involved in the care and management of rheumatic disease patients.
Learning Objectives
After viewing this program, participants will be better able to:
- Discuss the reasons why Mixed Connective Tissue Disease is not really mixed.
- Predict brain changes in the first month of daily opioid therapy and review implications for addiction and hyperalgesia.
- Evaluate the evidence and discussions that were used to generate the ACR treatment guidelines for lupus nephritis and assess new SLE therapies.
- Identify the features of IgG4-related disease.
- Assess mechanisms and prevention approaches for accelerated atherosclerosis in SLE.
- Describe the current state of the art treatment of ANCA–associated vasculitis.
- Define new mechanisms involved in the development of osteoarthritis.
- Illustrate the complex relationship between chronic kidney disease and bone disease in adults.
- Summarize the current concepts of low dose naltrexone in the treatment of fibromyalgia.
- Name the advances in the pathogenesis and treatment of sarcoidosis.
- Evaluate the latest research on the effect of arthritis on bone and cartilage.
- Appraise imaging of the immune system.
- List the legislative and regulatory issues facing rheumatologists.
- Formulate a treatment plan for scleroderma manifestations.
- Assess complementary and alternative medicine as it applies to rheumatology.
- Identify the clinical rheumatology questions that have been answered in the laboratory.
- List the therapeutic options available for psoriatic arthritis.
- Recall the latest data on myopathies from pathogeny to treatment.
- Summarize the news on bone erosion in rheumatoid arthritis.
- Discuss the latest research on interstitial lung disease.
- Identify the rheumatic manifestations of cancer.
- Describe unusual rheumatology cases and unusual presentations of common rheumatologic conditions as presented in the thieves’ market.
- Assess the translational science journey that was involved with glucocorticoid–induced osteoporosis.
- Compare combination treatment regimens in osteoporosis.
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Oakstone Publishing, LLC and A&R Education Group LLC. Oakstone Publishing, LLC is accredited by the ACCME to provide continuing medical education for physicians.
Date Of Original Release: January 15, 2015
Topics:
01 Beh‡et’s Syndrome Update 2014 Yusuf Yazici, M.D.mp4
02 Lupus Update 2014 Michele Petri, M.D., M.P.H.mp4
03 Scleroderma – Evidence of a Vascular Disease Fredrick Wigley, M.D.mp4
04 Infections and Autoimmunity – How Can We Harness Nature to Treat Autoimmune Diseases Yehuda Shoenfeld, M.D., FRCP.mp4
05 Vascular Treat to Target – Possible Strategy in Scleroderma Fredrick Wigley, M.D..mp4
06 ASIA AutoimmuneAutoinflammatory Syndrome – Induced by Adjuvants and Autoimmune Rheumatic Diesases, 2014 Yehuda Shoenfeld, M.D., FRCP.mp4
07 Central Pain Mechanisms in the Rheumatic Diseases Kristine Phillips, M.D., Ph.D..mp4
08 To D or Not to D – This is the Question Yehuda Shoenfeld, M.D., FRCP.mp4
09 Connective Tissue Disease and Dermatology Cutaneous Lupus, Dermatomyositis and Scleroderma Ruth Ann Vleugels, M.D., M.P.H.mp4
10 Antiphospholipid Antibody Syndrome Update Michele Petri, M.D., M.P.H.mp4
11 Cryoglobulinemia Peter Gorevic, M.D.mp4
12 Inclusion Body Myositis Thomas Lloyd, M.D., Ph.D.mp4
13 Clinical Cases in Rheumatology-Dermatology Ruth Ann Vleugels, M.D., M.P.H.mp4
14 CCR Thieves’ Market Alan Epstein, M.D., Moderator.mp4
15 Joint Hypermobility Syndrome – An Evolving Multi-System Disorder Rodney Grahame, M.D., FRCP.mp4
16 Gout Update Robert Keenan, M.D., M.P.H.mp4
17 Management of the Joint Hypermobility Syndrome Rodney Grahame, M.D., FRCP.mp4
18 What’s New in Spinal Osteoarthritis Alfred C. Gellhorn, M.D.mp4
19 Inflammatory Eye Diseases in the Rheumatic Disease Patient Robert Keenan, M.D., M.P.H.mp4
20 Disease Activity Measurement and Biomarkers in RA Max Hamburger, M.D.mp4
21 Current Legislative & Regulatory Issues Facing Rheumatologists Robert S. Jasak, J.D.mp4
22 Sequential Combination Therapy in Osteoporosis Felicia Cosman, M.D.mp4
23 Regulation of Bone Homeostasis Signaling Pathways and Novel Targets David W. Dempster, PhD, FRMS.mp4
24 Treatment to Goal in Osteoporosis Felicia Cosman, M.D.mp4
Questions.pdf
Syllabus.pdf
Related products
Uncategorized
Uncategorized
